Medical Management of Extremely Low-Birth-Weight Infants in the First Week of Life: A Survey of Practices in the United States

ABSTRACT

We sought to determine the current practices of neonatologists in their management of extremely low-birth-weight (< 1000 g) infants. We directly mailed an anonymous survey to the medical directors of 809 neonatal intensive care units in the United States. More than one-third of those surveyed responded, with a substantial majority from intensive care (level III) nurseries or extracorporeal membrane oxygenation centers. Academic centers and private practice environments were both well represented. Some traditional practices have changed, such as beginning resuscitation with 40% rather than 100% oxygen. Many practices vary based on whether neonates are cared for in private versus academic centers, including initial resuscitation method, type of ventilation used, use of intraventricular hemorrhage prophylaxis, and routine antibiotic therapy. Parenteral nutrition composition and the use of inhaled nitric oxide differ based on the responding center's participation in clinical trials. The number of years in practice as a neonatologist does not affect practice decisions. Among all our findings, the prevalence of one potentially harmful practice, the continued use of dexamethasone for corticosteroid therapy, was particularly noteworthy. In conclusion, the strength of evidence does not always predict whether practices are adopted or abandoned. Further research is necessary to clarify the optimal management for this high-risk patient population.

KEYWORDS

Extremely low birth weight - survey - practice variation - neonatal resuscitation - corticosteroids

REFERENCES

• 1 Resuscitation of Babies Born Preterm .In: Kattwinkel J Neonatal Resuscitation. 5th ed. American Academy of Pediatrics and the American Heart Association 2006: 8-1-8-16
• 2 Saugstad O D, Ramji S, Vento M. Resuscitation of depressed newborn infants with ambient air or pure oxygen: a meta-analysis.  Biol Neonate. 2005;  87 27-34
• 3 Tan A, Schulze A, O'Donnell C P, Davis P G. Air versus oxygen for resuscitation of infants at birth.  Cochrane Database Syst Rev. 2005;  (2) CD002273
• 4 Wang C L, Anderson C, Leone T A, Rich W, Govindaswami B, Finer N N. Resuscitation of preterm neonates using room air or 100% oxygen.  Pediatrics. 2008;  121 1083-1089
• 5 Courtney S E, Durand D J, Asselin J M, Hudak M L, Aschner J L, Shoemaker C T. High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants.  N Engl J Med. 2002;  347 643-652
• 6 Keszler M, Modanlou H D, Brudno D S et al.. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.  Pediatrics. 1997;  100 593-599
• 7 Fowlie P W, Davis P G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.  Cochrane Database Syst Rev. 2002;  (3) CD000174
• 8 Schmidt B, Davis P, Moddemann D et al.. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.  N Engl J Med. 2001;  344 1966-1972
• 9 Noori S, Friedlich P, Wong P, Ebrahimi M, Siassi B, Seri I. Hemodynamic changes after low-dosage hydrocortisone administration in vasopressor-treated preterm and term neonates.  Pediatrics. 2006;  118 1456-1466
• 10 Stark A R, Carlo W A, Tyson J E et al.. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants.  N Engl J Med. 2001;  344 95-100
• 11 LeFlore J L, Salhab W A, Broyles R S, Engle W D. Association of antenatal and postnatal dexamethasone exposure with outcomes in extremely low birth weight neonates.  Pediatrics. 2002;  110 275-279
• 12 Craft A P, Finer N N, Barrington K J. Vancomycin for prophylaxis against sepsis in preterm neonates.  Cochrane Database Syst Rev. 2000;  (2) CD001971
• 13 Clerihew L, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.  Cochrane Database Syst Rev. 2007;  (4) CD003850
• 14 Tyson J E, Kennedy K A. Trophic feedings for parenterally fed infants.  Cochrane Database Syst Rev. 2005;  (3) CD000504
• 15 Berseth C L, Bisquera J A, Paje V U. Prolonging small feeding volumes early in life decreases the incidence of necrotizing enterocolitis in very low birth weight infants.  Pediatrics. 2003;  111 529-534
• 16 Saugstad O D, Ramji S, Irani S F et al.. Resuscitation of newborn infants with 21% or 100% oxygen: follow-up at 18 to 24 months.  Pediatrics. 2003;  112 296-300
• 17 Engle WA and the Committee on Fetus and Newborn . Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.  Pediatrics. 2008;  121 419-432
• 18 Narendran V, Donovan E F, Hoath S B, Akinbi H T, Steichen J J, Jobe A H. Early bubble CPAP and outcomes in ELBW preterm infants.  J Perinatol. 2003;  23 195-199
• 19 Aly H, Milner J D, Patel K, El-Mohandes A AE. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants?.  Pediatrics. 2004;  114 697-702
• 20 Morley C J, Davis P G, Doyle L W et al.. Nasal CPAP or intubation at birth for very preterm infants.  N Engl J Med. 2008;  358 700-708
• 21 Henderson-Smart D J, Cools F, Bhuta T, Offringa M. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants.  Cochrane Database Syst Rev. 2007;  (3) CD000104
• 22 Truffert P, Paris-Llado J, Escande B et al.. Neuromotor outcome at 2 years of very preterm infants who were treated with high-frequency oscillatory ventilation or conventional ventilation for neonatal respiratory distress syndrome.  Pediatrics. 2007;  119 e860-e865
• 23 Vanderveen D K, Mansfield T A, Eichenwald E C. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity.  J AAPOS. 2006;  10 445-448
• 24 Askie L M, Henderson-Smart D J, Irwig L, Simpson J M. Oxygen-saturation targets and outcomes in extremely preterm infants.  N Engl J Med. 2003;  349 959-967
• 25 Barrington K J, Finer N N. Inhaled nitric oxide for respiratory failure in preterm infants.  Cochrane Database Syst Rev. 2007;  (3) CD000509
• 26 Van Meurs K P, Wright L L, Ehrenkranz R A et al.. Inhaled nitric oxide for premature infants with severe respiratory failure.  N Engl J Med. 2005;  353 13-22
• 27 Van Overmeire B, Allegaert K, Casaer A et al.. Prophylactic ibuprofen in premature infants; a multicentre, randomized, double blind, placebo-controlled trial.  Lancet. 2004;  364 1945-1949
• 28 Pezzati M, Vangi V, Biagotti R, Bertini G, Cianciulli D, Rubaltelli F. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus.  J Pediatr. 1999;  135 733-738
• 29 Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.  Cochrane Database Syst Rev. 2003;  (2) CD003481
• 30 Gournay V, Savagner C, Thiriez G, Kuster A, Roze J-C. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants.  Lancet. 2002;  359 1486-1488
• 31 Bellini C, Campone F, Serra G. Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus.  CMAJ. 2006;  174 1843-1844
• 32 Huysman M W, Hokken-Koelega A C, DeRidder M A, Sauer P J. Adrenal function in sick very preterm infants.  Pediatr Res. 2000;  48 629-633
• 33 Lemons J A, Bauer C R, Oh W et al.. Very low birth weight outcomes of the National Institutes of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996.  Pediatrics. 2001;  107 E1
• 34 Halliday H L, Ehrenkranz R A, Doyle L W. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants.  Cochrane Database Syst Rev. 2003;  (1) CD001146
• 35 The Vermont Oxford Network Steroid Study Group . Early postnatal dexamethasone therapy for prevention of chronic lung disease.  Pediatrics. 2001;  108 741-748
• 36 Karemaker R, Kavelaars A, ter Wolbeek M et al.. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age.  Pediatrics. 2008;  121 e870-e878
• 37 Watterberg K L, Gerdes J S, Cole C H et al.. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial.  Pediatrics. 2004;  114 1649-1657
• 38 Watterberg K L, Shaffer M L, Mishefske M J et al.. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.  Pediatrics. 2007;  120 40-48
• 39 American Academy of Pediatrics Committee on Fetus and Newborn, Canadian Paediatric Society Fetus and Newborn Committee . Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.  Pediatrics. 2002;  109 330-338
• 40 Doyle L W, Davis P G, Morley C J, McPhee A, Carlin J B. the DART study investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized controlled trial.  Pediatrics. 2006;  117 75-83
• 41 Attridge J T, Clark R, Walker M W, Gordon P V. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure.  J Perinatol. 2006;  26 93-99
• 42 Thureen P J, Hay Jr W W. Intravenous nutrition and postnatal growth of the micropremie.  Clin Perinatol. 2000;  27 197-219
• 43 Simmer K, Rao S C. Early introduction of lipids to parenterally-fed preterm infants.  Cochrane Database Syst Rev. 2005;  (2) CD005256
• 44 Poindexter B B, Langer J C, Dusick A M, Ehrenkranz R A. Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelopmental outcome.  J Pediatr. 2006;  148 300-305
• 45 Clark R H, Chace D H, Spitzer A R. for the Pediatrix Amino Acid Study Group . Effects of two different doses of amino acid supplementation on growth and blood amino acid levels in premature neonates admitted to the neonatal intensive care unit: a randomized, controlled trial.  Pediatrics. 2007;  120 1286-1296
• 46 Guillet R, Stoll B J, Cotton C M et al.. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants.  Pediatrics. 2006;  117 e137-e142
• 47 American Academy of Pediatrics . Section on Breastfeeding. Policy Statement: breastfeeding and the use of human milk.  Pediatrics. 2005;  115 496-506
• 48 Schanler R J, Lau C, Hurst N M, O'Brian Smith E. Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants.  Pediatrics. 2005;  116 400-406
• 49 Davey A M, Wagner C L, Cox C, Kendig J W. Feeding premature infants while low umbilical artery catheters are in place: a prospective, randomized trial.  J Pediatr. 1994;  124 795-799
• 50 Darlow B A, Graham P J. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants.  Cochrane Database Syst Rev. 2007;  (4) CD000501
• 51 Tyson J E, Wright L L, Oh W. Vitamin A supplementation for extremely-low-birth-weight infants.  N Engl J Med. 1999;  340 1962-1968
• 52 Ambalavanan N, Kennedy K, Tyson J, Carlo W A. Survey of vitamin A supplementation for extremely-low-birth-weight infants: is clinical practice consistent with the evidence?.  J Pediatr. 2004;  145 304-307
• 53 Brion L P, Bell E F, Raghuveer T S. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants.  Cochrane Database Syst Rev. 2003;  (3) CD003665
• 54 Hodgman J E, Barton L, Pavlova Z, Fassett M J. Infection as a cause of death in the extremely-low-birth-weight infant.  J Matern Fetal Neonatal Med. 2003;  14 313-317
• 55 Stoll B J, Gordon T, Korones S B et al.. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network.  J Pediatr. 1996;  129 72-80
• 56 American Academy of Pediatrics, Committee on Infectious Disease and Committee on Fetus and Newborn . Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection.  Pediatrics. 1997;  99 489-496
• 57 World Health Organization Department of Child and Adolescent Health and Development .Explore Simplified Antimicrobial Regimens for the Treatment of Neonatal Sepsis. Meeting report, September 30 to October 1, 2002 Geneva, Switzerland; WHO 2003 (WHO/FCH/CAH/04.1)
• 58 Modi N, Damjanovic V, Cooke R W. Outbreak of cephalosporin- resistant Enterobacter cloacae infection in a neonatal intensive care unit.  Arch Dis Child. 1987;  62 148-151
• 59 Clark R H, Bloom B T, Spitzer A R, Gerstmann D R. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death.  Pediatrics. 2006;  117 67-74
• 60 Stoll B J, Hansen N, Fanaroff A A et al.. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.  Pediatrics. 2002;  110 285-291
• 61 Maayan-Metzger A, Linder N, Marom D, Vishne T, Ashkenazi S, Sirota L. Clinical and laboratory impact of coagulase-negative staphylococci bacteremia in preterm infants.  Acta Paediatr. 2000;  89 690-693
• 62 Gray J E, Richardson D K, McCormick M C, Goldmann D A. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome.  Pediatrics. 1995;  95 225-230
• 63 Center for Disease Control and Prevention . Guidelines for the prevention of intravascular catheter-related infections.  MMWR Recomm Rep. 2002;  51(RR-10) 1-29
• 64 Benjamin Jr D K, Stoll B J, Fanaroff A A et al.. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.  Pediatrics. 2006;  117 84-92